Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00490646
Status:
COMPLETED
Last Update Posted:
2016-03-10
First Post:
2007-06-21
Brief Title:
A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced andor Metastatic Breast Cancer
Sponsor:
R-Pharm
Organization:
R-Pharm
Organization Data
Organization:
R-Pharm
Class:
INDUSTRY
Study ID:
CA163-140
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
R-Pharm
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None